SOUTH SAN FRANCISCO, Calif., December 13, 2023 – GenEdit, Inc., a developer of genetic medicines that leverage its NanoGalaxy® platform for tissue-selective delivery, today announced that it is a Phase I winner of the National Institutes of Health (NIH) TARGETED Challenge for programmable delivery systems for gene editing. GenEdit’s application highlighted delivery to the nervous, immune, and other […] The post GenEdit Is a Phase I Winner of the NIH TARGETED Challenge first appeared on BreezeBio .
Discovery
Learnings
- auto_storiesStories
- categoryAreas
- helpFAQ
- forumConversations
- descriptionPapers
- mailNewsletters
- video_libraryVideos
- timelineTimeline
Guidance
- codeTechnology of APIs
- business_centerBusiness of APIs
- campaignEvangelism of APIs
- gavelGovernance of APIs
- historyHistory of APIs
- account_balancePolitics of APIs
Toolbox
- domainProviders
- apiAPIs
- cloudSolutions
- buildTools
- verifiedStandards
- gavelRegulations
- horizontal_ruleHeaders
- layersOverlays
- extensionExtensions
- schemaSchema
- policyPolicies
- ruleRules